Fidelity Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.62M | Buy |
|
|||||
|
2025
Q2 | $2.22M | Sell |
|
|||||
|
2025
Q1 | $3.63M | Buy |
|
|||||
|
2024
Q4 | $1.5M | Buy |
|
|||||
|
2024
Q3 | $1.01M | Buy |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Sell |
|
|||||
|
2023
Q4 | $1.84M | Sell |
|
|||||
|
2023
Q3 | $1.7M | Buy |
|
|||||
|
2023
Q2 | $1.96M | Sell |
|
|||||
|
2023
Q1 | $2.03M | Buy |
|
|||||
|
2022
Q4 | $1.86M | Sell |
|
|||||
|
2022
Q3 | $2.62M | Buy |
|
|||||
|
2022
Q2 | $2.84M | Buy |
|
|||||
|
2022
Q1 | $3.52M | Buy |
|
|||||
|
2021
Q4 | $21K | Buy |
|
|||||
|
2021
Q3 | $4K | Buy |
|
|||||
|
2021
Q2 | $4K | Sell |
|
|||||
|
2021
Q1 | $4K | Buy |
|
|||||
|
2020
Q4 | $3K | Sell |
|
|||||
|
2020
Q3 | $8.32M | Buy |
|
|||||
|
2020
Q2 | $3K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $6K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $14.2M | Sell |
|
|||||
|
2017
Q3 | $17.4M | Sell |
|
|||||
|
2017
Q2 | $29.6M | Sell |
|
|||||
|
2017
Q1 | $40.1M | Sell |
|
|||||
|
2016
Q4 | $56.7M | Sell |
|
|||||
|
2016
Q3 | $147M | Sell |
|
|||||
|
2016
Q2 | $188M | Buy |
|
|||||
|
2016
Q1 | $248M | Buy |
|
|||||
|
2015
Q4 | $301M | Buy |
|
|||||
|
2015
Q3 | $123M | Sell |
|
|||||
|
2015
Q2 | $249M | Buy |
|
|||||
|
2015
Q1 | $295M | Buy |
|
|||||
|
2014
Q4 | $283M | Sell |
|
|||||
|
2014
Q3 | $309M | Buy |
|
|||||
|
2014
Q2 | $285M | Sell |
|
|||||
|
2014
Q1 | $220M | Sell |
|
|||||
|
2013
Q4 | $212M | Buy |
|
|||||
|
2013
Q3 | $167M | Buy |
|
|||||
|
2013
Q2 | $78.2M | Buy |
|